All News

Doctors say patients with cancer face distinct risks during the cyclosporiasis outbreak that spans 45 states.

After moving two hours away, a survivor weighs staying with the cancer center that knows her history against finding an oncologist close to home.

Sanita Burgic, of Washington University Siteman Cancer Center, combines clinical excellence and deep empathy to support cancer patients and elevate her entire oncology team.

Dr. Priscilla Merriam discusses how sarcomas can be mistaken for benign growths like lipomas and fibroids, and why asking about a biopsy can matter before surgery.

Lung cancer advocate Katie shares how losing her father to the disease and her own cancer journey inspire her work with LiveLung today.

Multiple myeloma and breast cancer survivor Valerie Traynham shares why survivorship begins at diagnosis and offers hope, resilience and life after cancer insights.

An oncologist explains why the choice between removing one lobe or the whole thyroid should be a conversation, not a surprise.

Noreen Walsh, RN, MSN, OCN, of St. Francis Hospital and Cancer Institute, builds deep personal bonds with cancer patients and families that extend far beyond clinical care.

Dr. Robert S. Alter discusses what to ask before thyroid surgery, why "active surveillance" isn't passive and how targeted therapy is changing outcomes.

FDA approves Tudriqev plus Opdivo for adults with advanced melanoma that progressed after PD-1 immunotherapy, expanding treatment options.

After my insurance denied the cancer treatment that worked, every appeal failed. Here's how resilience and advocacy helped me move forward.

An incidental CT scan revealed stage 1A lung cancer. After robotic surgery at Hackensack University Medical Center, Carolyn Rothfeld describes a recovery that took longer than she expected.

After receiving a stage 1 lung cancer diagnosis, Carolyn Rothfeld underwent robotic surgery to remove part of her lung and is back to her exercise routine nine months later.

After breast cancer, one survivor reflects on reclaiming her life by remodeling her kitchen and embracing the freedom to focus on something beyond cancer.

High-risk multiple myeloma is identified through bone marrow testing and can help guide treatment decisions, from combination therapy to clinical trials.

Diagnosed with stage 1 lung cancer at 40, Gillian Ryan shares the overwhelming guilt she felt about bringing cancer into her family’s life.

Learn how Talvey plus Tecvayli cut the risk of myeloma progression or death by 89%, how the combination is given and what it may mean for daily life.

Dr. Mark Zhao explains how minimally invasive techniques preserve function, speed recovery and why patients should not wait years to raise bowel symptoms with their doctor.

Six years after follicular lymphoma treatment, a follow-up CT scan brought encouraging news—but the fear of recurrence and uncertainty still linger.

Luciana Lopes Manfredini, of Einstein Hospital Israelita in São Paulo, Brazil, developed a triage scale for emergency cancer patients now being adopted across North and Latin America.

Melanie Diaz, DNP, NP-C, OCN, of St. Francis Cancer Institute, blends firm accountability with deep empathy to keep cancer patients engaged and empowered throughout treatment.

Diagnosed with limited-stage small-cell lung cancer, Tammy shares how treatment progress and a mindset shift helped her find hope.

The 10-3 vote came during a discussion in which the limitations of TIL therapy, the only approved option for this group of patients, were raised repeatedly.

The FDA approved Pluvicto with hormone therapy for PSMA-positive metastatic prostate cancer, helping delay disease progression in patients.

Patients with advanced biliary tract cancer lived longer on Imfinzi (durvalumab) plus chemotherapy than on chemotherapy alone, according to four-year follow-up data from the phase 3 TOPAZ-1 trial.

Tafinlar plus Mekinist extended progression-free survival to 12.8 months vs. 3.7 months with placebo in BRAF V600E-positive thyroid cancer.

After surviving testicular cancer, one survivor shares how writing, faith, running and hope helped him heal and embrace a meaningful life after treatment.

Heather Prather shares her stage 4 non small cell lung cancer journey, finding hope, joy and support through the LiveLung community and cancer advocacy.